OTC · Biotechnology

EOM Pharmaceuticals Holdings, Inc. (IMUC) Stock

$0.25 +90.77% OTC: IMUC Healthcare

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications.

Valuation

MetricValue
Price$0.25
Market Cap$31.37M
P/E Ratio-16.32
P/B Ratio-13.10
P/S Ratio0.00
EPS (TTM)$-0.02
52-Week High$0.34
52-Week Low$0.04
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE127.66%
ROA-440.45%
ROCE170.40%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.73
Current Ratio0.08

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-3.0M$-2.0M$-2.0M$-2.0M
Net Profit$-3.0M$-3.0M$-2.0M$-2.0M$-2.0M
EPS$-0.06$-0.02$-0.01$-0.02$-0.02
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$1.0M$0$0$0
Total Liabilities$3.0M$5.0M$6.0M$1.0M$2.0M
Cash$1.0M$1.0M$0$0$0
Borrowings$3.0M$3.0M$5.0M$0$2.0M

Latest News

EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients GlobeNewswire · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-3.0M$-1.0M$-3.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$1.0M$-1.0M$0$0$0
Free Cash Flow$-2.0M$-3.0M$-1.0M$-3.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA-18.11
FCF Yield-4.76%
Quick Ratio0.08
Interest Coverage-19.24
Return 1Y217.95%
Return 3Y-36.08%
Return 5Y-48.33%

Ownership

Insiders Held94.97%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALDXAldeyra Therapeutics, Inc. $0.96 +1.11% -3.02 $57.80M 0.00%
ATYRaTyr Pharma, Inc. $0.25 -2.23% -0.46 $24.47M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CLNNClene Inc. $3.87 -0.26% -1.10 $49.45M 0.00%
CVMCel-Sci Corporation $1.93 -1.04% -0.90 $13.26M 0.00%

About EOM Pharmaceuticals Holdings, Inc.

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey.

EOM Pharmaceuticals Holdings, Inc. is headquartered in US.

EOM Pharmaceuticals Holdings, Inc. (IMUC) stock trades at $0.25 with a market capitalization of $31.37M. The stock is valued at a price-to-earnings (P/E) ratio of -16.32, price-to-book of -13.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.04 and $0.34, and currently trades 26.5% below its 52-week high.

On profitability, EOM Pharmaceuticals Holdings, Inc. generates a return on equity (ROE) of 127.66% — well above the market average, a sign of a high-quality business, return on capital employed of 170.40%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.eompharma.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.48 +0.50% JNJ Johnson & Johnson $260.70 +1.65% ABBV AbbVie Inc. $276.78 +1.60% MRK Merck & Company, Inc. Common Stock (new) $146.11 +2.62% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.44 +2.29% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $660.73 +1.34% AMGN Amgen Inc. $417.21 +2.40% GILD Gilead Sciences, Inc. $151.27 +2.83% ABT Abbott Laboratories $99.16 +0.68% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides